CHEMOTHERAPY PRINCIPLES IN THE TREATMENT OF PROSTATIC-CANCER

被引:12
作者
KONYVES, I [1 ]
MUNTZING, J [1 ]
ROZENCWEIG, M [1 ]
机构
[1] INST JULES BORDET,B-1000 BRUSSELS,BELGIUM
关键词
D O I
10.1002/pros.2990050106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:55 / 62
页数:8
相关论文
共 46 条
[31]  
SAROSDY MF, 1982, CANCER, V50, P1332, DOI 10.1002/1097-0142(19821001)50:7<1332::AID-CNCR2820500719>3.0.CO
[32]  
2-8
[33]   CHEMOTHERAPY OF HORMONE-RESISTANT STAGE-D PROSTATIC-CANCER [J].
SCHMIDT, JD .
JOURNAL OF UROLOGY, 1980, 123 (06) :797-805
[34]   A CRITICAL-APPRAISAL OF THE HUMAN-TUMOR STEM-CELL ASSAY [J].
SELBY, P ;
BUICK, RN ;
TANNOCK, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (03) :129-133
[35]   A PHASE-II EVALUATION OF A 3-DRUG COMBINATION OF CYCLOPHOSPHAMIDE, DOXORUBICIN AND 5-FLUOROURACIL AND OF 5-FLUOROURACIL IN PATIENTS WITH ADVANCED BLADDER-CARCINOMA OR STAGE-D PROSTATIC-CARCINOMA [J].
SMALLEY, RV ;
BARTOLUCCI, AA ;
HEMSTREET, G ;
HESTER, M .
JOURNAL OF UROLOGY, 1981, 125 (02) :191-195
[36]   CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE AND 5-FLUOROURACIL IN ADVANCED-CARCINOMA OF THE PROSTATE [J].
SOLOWAY, MS ;
SHIPPEL, RM ;
IKARD, M .
JOURNAL OF UROLOGY, 1979, 122 (05) :637-639
[37]   STIMULATORY AND INHIBITORY EFFECTS OF ESTROGEN ON UTERINE DNA-SYNTHESIS [J].
STORMSHAK, F ;
LEAKE, R ;
WERTZ, N ;
GORSKI, J .
ENDOCRINOLOGY, 1976, 99 (06) :1501-1511
[38]  
STRAUS MJ, 1982, P AACR ASCO, V23, P115
[39]  
SUAREZ AJ, 1982, CANCER CHEMOTH PHARM, V8, P261
[40]   THE CHEMOTHERAPY OF PROSTATIC ADENOCARCINOMA [J].
TORTI, FM ;
CARTER, SK .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (05) :681-689